BC-CfE partners with UNAIDS to accelerate access to HIV treatment

The BC Centre for Excellence in HIV/AIDS (BC-CfE) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) have announced a partnership that will accelerate HIV treatment access globally.

On February 5, at a meeting at the UNAIDS headquarters in Geneva, Switzerland, the two organizations formalized their partnership to support efforts to bring HIV treatment to all eligible people.

“Julio Montaner and his colleagues at the BC Centre for Excellence in HIV/AIDS are globally recognized for their work on HIV treatment and we are happy to continue this long partnership,” UNAIDS Executive Director Michel Sidibé.

Since 2006 Dr. Julio Montaner has called for the implementation of Treatment as Prevention™, a strategy he pioneered at the BC-CfE calling for widespread HIV testing and immediate provision of highly effective antiretroviral therapy to those living with HIV. The TasP¨â„¢ strategy can eliminate progression of HIV infection to AIDS and premature death, and significantly decrease the amount of virus in the blood and sexual fluids, thereby stopping transmission of HIV.

In 2010 UNAIDS officially endorsed the strategy and, in 2013, they launched the Treatment 2015 framework, a blueprint for the elimination of HIV calling for intensified action and innovation to expedite treatment scale-up.

“We’re very excited to further our relationship with UNAIDS, and to bring the Treatment as Prevention™ model to the world,” said Dr. Montaner.

Under the new partnership, the BC-CfE will support scientific modelling and activities to highlight the need for immediate investments in life-saving HIV treatment programs.

Read the UNAIDS announcement here.

Share the Post:
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below